Pretreatment (18)F‐FDG Uptake Heterogeneity Predicts Treatment Outcome of First‐Line Chemotherapy in Patients with Metastatic Triple‐Negative Breast Cancer

BACKGROUND. Intratumoral heterogeneity of (18)F‐fluorodeoxyglucose ((18)F‐FDG) uptake in primary tumor has proven to be a surrogate marker for predicting treatment outcome in various tumors. However, the value of intraindividual heterogeneity in metastatic diseases remains unknown. The aim of this s...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Gong, Chengcheng, Ma, Guang, Hu, Xichun, Zhang, Yingjian, Wang, Zhonghua, Zhang, Jian, Zhao, Yannan, Li, Yi, Xie, Yizhao, Yang, Zhongyi, Wang, Biyun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2018
Aiheet:
Breast Cancer
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6263118/
https://ncbi.nlm.nih.gov/pubmed/30082489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0001
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia